Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Andrzej Niemierko, PH.D.

TitleAssociate Professor of Radiation Oncology
InstitutionMassachusetts General Hospital
DepartmentRadiation Oncology
AddressMassachusetts General Hospital
Dept of Radiation Oncology
10 Emerson #122
Boston MA 02114
Phone617/724-9527
Fax617/726-2098

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Aizer AA, Paly JJ, Zietman AL, Nguyen PL, Beard CJ, Rao SK, Kaplan ID, Niemierko A, Hirsch MS, Wu CL, Olumi AF, Michaelson MD, D'Amico AV, Efstathiou JA. Models of Care and NCCN Guideline Adherence in Very-Low-Risk Prostate Cancer. J Natl Compr Canc Netw. 2013 Nov 1; 11(11):1364-72.
    View in: PubMed
  2. Rochet N, Kahn RS, Niemierko A, Delaney TF, Russell AH. Consolidation whole abdomen irradiation following adjuvant carboplatin-paclitaxel based chemotherapy for advanced uterine epithelial cancer: feasibility, toxicity and outcomes. Radiat Oncol. 2013; 8(1):236.
    View in: PubMed
  3. Sadek BT, Shenouda MN, Abi Raad RF, Niemierko A, Keruakous AR, Goldberg SI, Taghian AG. Risk of Local Failure in Breast Cancer Patients With Lobular Carcinoma In Situ at the Final Surgical Margins: Is Re-excision Necessary? Int J Radiat Oncol Biol Phys. 2013 Nov 15; 87(4):726-30.
    View in: PubMed
  4. Specht MC, Miller CL, Russell TA, Horick N, Skolny MN, O'Toole JA, Jammallo LS, Niemierko A, Sadek BT, Shenouda MN, Finkelstein DM, Smith BL, Taghian AG. Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression? Breast Cancer Res Treat. 2013 Aug; 140(3):485-94.
    View in: PubMed
  5. Sethi RV, Marino R, Niemierko A, Tarbell NJ, Yock TI, Macdonald SM. Delayed diagnosis in children with intracranial germ cell tumors. J Pediatr. 2013 Nov; 163(5):1448-53.
    View in: PubMed
  6. Russo AL, Arvold ND, Niemierko A, Wong N, Wong JS, Bellon JR, Punglia RS, Golshan M, Troyan SL, Brock JE, Harris JR. Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy. Breast Cancer Res Treat. 2013 Jul; 140(2):353-61.
    View in: PubMed
  7. O'Toole J, Miller CL, Specht MC, Skolny MN, Jammallo LS, Horick N, Elliott K, Niemierko A, Taghian AG. Cording following treatment for breast cancer. Breast Cancer Res Treat. 2013 Jul; 140(1):105-11.
    View in: PubMed
  8. Giantsoudi D, Grassberger C, Craft D, Niemierko A, Trofimov A, Paganetti H. Linear energy transfer-guided optimization in intensity modulated proton therapy: feasibility study and clinical potential. Int J Radiat Oncol Biol Phys. 2013 Sep 1; 87(1):216-22.
    View in: PubMed
  9. Zeng C, Giantsoudi D, Grassberger C, Goldberg S, Niemierko A, Paganetti H, Efstathiou JA, Trofimov A. Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions. Med Phys. 2013 May; 40(5):051708.
    View in: PubMed
  10. Coen JJ, Paly JJ, Niemierko A, Kaufman DS, Heney NM, Spiegel DY, Efstathiou JA, Zietman AL, Shipley WU. Nomograms predicting response to therapy and outcomes after bladder-preserving trimodality therapy for muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys. 2013 Jun 1; 86(2):311-6.
    View in: PubMed
  11. Choi NC, Chun TT, Niemierko A, Ancukiewicz M, Fidias PM, Kradin RL, Mathisen DJ, Lynch TJ, Fischman AJ. Potential of (18)F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer. Eur J Nucl Med Mol Imaging. 2013 Jun; 40(6):832-41.
    View in: PubMed
  12. Arvold ND, Oh KS, Niemierko A, Taghian AG, Lin NU, Abi-Raad RF, Sreedhara M, Harris JR, Alexander BM. Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype. Breast Cancer Res Treat. 2012 Nov; 136(1):153-60.
    View in: PubMed
  13. Aizer AA, Paly JJ, Zietman AL, Nguyen PL, Beard CJ, Rao SK, Kaplan ID, Niemierko A, Hirsch MS, Wu CL, Olumi AF, Michaelson MD, D'Amico AV, Efstathiou JA. Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer. J Clin Oncol. 2012 Sep 1; 30(25):3071-6.
    View in: PubMed
  14. Dennis ER, Bussiere MR, Niemierko A, Lu MW, Fullerton BC, Loeffler JS, Shih HA. A Comparison of Critical Structure Dose and Toxicity Risks in Patients with Low Grade Gliomas Treated with IMRT versus Proton Radiation Therapy. Technol Cancer Res Treat. 2013 Feb; 12(1):1-9.
    View in: PubMed
  15. Nardi V, Winkfield KM, Ok CY, Niemierko A, Kluk MJ, Attar EC, Garcia-Manero G, Wang SA, Hasserjian RP. Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms. J Clin Oncol. 2012 Jul 1; 30(19):2340-7.
    View in: PubMed
  16. Arvold ND, Willett CG, Fernandez-del Castillo C, Ryan DP, Ferrone CR, Clark JW, Blaszkowsky LS, Deshpande V, Niemierko A, Allen JN, Kwak EL, Wadlow RC, Zhu AX, Warshaw AL, Hong TS. Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapy. Int J Radiat Oncol Biol Phys. 2012 Jul 1; 83(3):e337-43.
    View in: PubMed
  17. Efstathiou JA, Paly JJ, Lu HM, Athar BS, Moteabbed M, Niemierko A, Adams JA, Bekelman JE, Shipley WU, Zietman AL, Paganetti H. Adjuvant radiation therapy for early stage seminoma: proton versus photon planning comparison and modeling of second cancer risk. Radiother Oncol. 2012 Apr; 103(1):12-7.
    View in: PubMed
  18. Allen Li X, Alber M, Deasy JO, Jackson A, Ken Jee KW, Marks LB, Martel MK, Mayo C, Moiseenko V, Nahum AE, Niemierko A, Semenenko VA, Yorke ED. The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Med Phys. 2012 Mar; 39(3):1386-409.
    View in: PubMed
  19. Arvold ND, Niemierko A, Broussard GP, Adams J, Fullerton B, Loeffler JS, Shih HA. Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):e495-500.
    View in: PubMed
  20. Zhang K, Liu Y, Yang JY, Arabnia HR, Niemierko A, Ghafoor A, Li W, Deng Y. From genes to networks: in systematic points of view. BMC Syst Biol. 2011 Dec 23; 5 Suppl 3:I1.
    View in: PubMed
  21. Mak RH, Alexander BM, Asomaning K, Heist RS, Liu CY, Su L, Zhai R, Ancukiewicz M, Napolitano B, Niemierko A, Willers H, Choi NC, Christiani DC. A single-nucleotide polymorphism in the methylene tetrahydrofolate reductase (MTHFR) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy. Cancer. 2012 Jul 15; 118(14):3654-65.
    View in: PubMed
  22. Hattangadi JA, Chapman PH, Bussière MR, Niemierko A, Ogilvy CS, Rowell A, Daartz J, Loeffler JS, Shih HA. Planned two-fraction proton beam stereotactic radiosurgery for high-risk inoperable cerebral arteriovenous malformations. Int J Radiat Oncol Biol Phys. 2012 Jun 1; 83(2):533-41.
    View in: PubMed
  23. Efstathiou JA, Spiegel DY, Shipley WU, Heney NM, Kaufman DS, Niemierko A, Coen JJ, Skowronski RY, Paly JJ, McGovern FJ, Zietman AL. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. Eur Urol. 2012 Apr; 61(4):705-11.
    View in: PubMed
  24. Arvold ND, Ryan DP, Niemierko A, Blaszkowsky LS, Kwak EL, Wo JY, Allen JN, Clark JW, Wadlow RC, Zhu AX, Fernandez-Del Castillo C, Hong TS. Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer. Cancer. 2012 Jun 15; 118(12):3026-35.
    View in: PubMed
  25. Alexander BM, Wang XZ, Niemierko A, Weaver DT, Mak RH, Roof KS, Fidias P, Wain J, Choi NC. DNA repair biomarkers predict response to neoadjuvant chemoradiotherapy in esophageal cancer. Int J Radiat Oncol Biol Phys. 2012 May 1; 83(1):164-71.
    View in: PubMed
  26. Arvold ND, Taghian AG, Niemierko A, Abi Raad RF, Sreedhara M, Nguyen PL, Bellon JR, Wong JS, Smith BL, Harris JR. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol. 2011 Oct 10; 29(29):3885-91.
    View in: PubMed
  27. Alexander BM, Fernandez-Del Castillo C, Ryan DP, Kachnic LA, Hezel AF, Niemierko A, Willett CG, Kozak KR, Blaszkowsky LS, Clark JW, Warshaw AL, Hong TS. Intraductal papillary mucinous adenocarcinoma of the pancreas: clinical outcomes, prognostic factors, and the role of adjuvant therapy. Gastrointest Cancer Res. 2011 Jul; 4(4):116-21.
    View in: PubMed
  28. Winkfield KM, Niemierko A, Bussiere MR, Crowley EM, Napolitano BN, Beaudette KP, Loeffler JS, Shih HA. Modeling intracranial second tumor risk and estimates of clinical toxicity with various radiation therapy techniques for patients with pituitary adenoma. Technol Cancer Res Treat. 2011 Jun; 10(3):243-51.
    View in: PubMed
  29. Son CH, Jimenez R, Niemierko A, Loeffler JS, Oh KS, Shih HA. Outcomes after whole brain reirradiation in patients with brain metastases. Int J Radiat Oncol Biol Phys. 2012 Feb 1; 82(2):e167-72.
    View in: PubMed
  30. Coen JJ, Paly JJ, Niemierko A, Weyman E, Rodrigues A, Shipley WU, Zietman AL, Talcott JA. Long-term quality of life outcome after proton beam monotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2012 Feb 1; 82(2):e201-9.
    View in: PubMed
  31. Hattangadi-Gluth JA, Wo JY, Nguyen PL, Abi Raad RF, Sreedhara M, Niemierko A, Freer PE, Georgian-Smith D, Bellon JR, Wong JS, Smith BL, Harris JR, Taghian AG. Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2012 Mar 1; 82(3):1185-91.
    View in: PubMed
  32. Ciernik IF, Niemierko A, Harmon DC, Kobayashi W, Chen YL, Yock TI, Ebb DH, Choy E, Raskin KA, Liebsch N, Hornicek FJ, Delaney TF. Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma. Cancer. 2011 Oct 1; 117(19):4522-30.
    View in: PubMed
  33. Abi-Raad R, Boutrus R, Wang R, Niemierko A, Macdonald S, Smith B, Taghian AG. Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys. 2011 Nov 1; 81(3):e151-7.
    View in: PubMed
  34. Yang JY, Niemierko A, Bajcsy R, Xu D, Athey BD, Zhang A, Ersoy OK, Li GZ, Borodovsky M, Zhang JC, Arabnia HR, Deng Y, Dunker AK, Liu Y, Ghafoor A. 2K09 and thereafter : the coming era of integrative bioinformatics, systems biology and intelligent computing for functional genomics and personalized medicine research. BMC Genomics. 2010; 11 Suppl 3:I1.
    View in: PubMed
  35. Goldberg SI, Shubina M, Niemierko A, Turchin A. A Weighty Problem: Identification, Characteristics and Risk Factors for Errors in EMR Data. AMIA Annu Symp Proc. 2010; 2010:251-5.
    View in: PubMed
  36. Kahn J, Loeffler JS, Niemierko A, Chiocca EA, Batchelor T, Chakravarti A. Long-term outcomes of patients with spinal cord gliomas treated by modern conformal radiation techniques. Int J Radiat Oncol Biol Phys. 2011 Sep 1; 81(1):232-8.
    View in: PubMed
  37. Halasz LM, Bussière MR, Dennis ER, Niemierko A, Chapman PH, Loeffler JS, Shih HA. Proton stereotactic radiosurgery for the treatment of benign meningiomas. Int J Radiat Oncol Biol Phys. 2011 Dec 1; 81(5):1428-35.
    View in: PubMed
  38. Goldberg SI, Niemierko A, Shubina M, Turchin A. "Summary Page": a novel tool that reduces omitted data in research databases. BMC Med Res Methodol. 2010; 10:91.
    View in: PubMed
  39. Devisetty K, Kobayashi W, Suit HD, Goldberg SI, Niemierko A, Chen YL, Raskin KA, Schwab JH, Springfield DS, Yoon SS, Hornicek FJ, DeLaney TF. Low-dose neoadjuvant external beam radiation therapy for soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2011 Jul 1; 80(3):779-86.
    View in: PubMed
  40. Arvold ND, Niemierko A, Mamon HJ, Fernandez-del Castillo C, Hong TS. Pancreatic cancer tumor size on CT scan versus pathologic specimen: implications for radiation treatment planning. Int J Radiat Oncol Biol Phys. 2011 Aug 1; 80(5):1383-90.
    View in: PubMed
  41. Hofstetter B, Niemierko A, Forrer C, Benhattar J, Albertini V, Pruschy M, Bosman FT, Catapano CV, Ciernik IF. Impact of genomic methylation on radiation sensitivity of colorectal carcinoma. Int J Radiat Oncol Biol Phys. 2010 Apr; 76(5):1512-9.
    View in: PubMed
  42. Talcott JA, Rossi C, Shipley WU, Clark JA, Slater JD, Niemierko A, Zietman AL. Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer. JAMA. 2010 Mar 17; 303(11):1046-53.
    View in: PubMed
  43. Zhang M, Coen JJ, Suzuki Y, Siedow MR, Niemierko A, Khor LY, Pollack A, Zhang Y, Zietman AL, Shipley WU, Chakravarti A. Survivin is a potential mediator of prostate cancer metastasis. Int J Radiat Oncol Biol Phys. 2010 Nov 15; 78(4):1095-103.
    View in: PubMed
  44. Suit H, DeLaney T, Goldberg S, Paganetti H, Clasie B, Gerweck L, Niemierko A, Hall E, Flanz J, Hallman J, Trofimov A. Proton vs carbon ion beams in the definitive radiation treatment of cancer patients. Radiother Oncol. 2010 Apr; 95(1):3-22.
    View in: PubMed
  45. Boutrus R, Abi-Raad R, Niemierko A, Brachtel EF, Rizk L, Kelada A, Taghian AG. Does lymphovascular invasion predict regional nodal failure in breast cancer patients with zero to three positive lymph nodes treated with conserving surgery and radiotherapy? Implications for regional radiation. Int J Radiat Oncol Biol Phys. 2010 Nov 1; 78(3):793-8.
    View in: PubMed
  46. Sanghani M, Truong PT, Raad RA, Niemierko A, Lesperance M, Olivotto IA, Wazer DE, Taghian AG. Validation of a web-based predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy. J Clin Oncol. 2010 Feb 10; 28(5):718-22.
    View in: PubMed
  47. Yang MQ, Niemierko A, Yang JY, Jin Y. Promoting inter/multidisciplinary education and research in bioinformatics, systems biology and intelligent computing. Int J Comput Biol Drug Des. 2009; 2(3):207-20.
    View in: PubMed
  48. Alm El-Din MA, Hughes KS, Raad RA, Goldberg SI, Aisenberg AC, Niemierko A, Taghian AG. Clinical outcome of breast cancer occurring after treatment for Hodgkin's lymphoma: case-control analysis. Radiat Oncol. 2009; 4:19.
    View in: PubMed
  49. Patel AA, Wolfgang JA, Niemierko A, Hong TS, Yock T, Choi NC. Implications of respiratory motion as measured by four-dimensional computed tomography for radiation treatment planning of esophageal cancer. Int J Radiat Oncol Biol Phys. 2009 May 1; 74(1):290-6.
    View in: PubMed
  50. Macdonald SM, Abi-Raad RF, Alm El-Din MA, Niemierko A, Kobayashi W, McGrath JJ, Goldberg SI, Powell S, Smith B, Taghian AG. Chest wall radiotherapy: middle ground for treatment of patients with one to three positive lymph nodes after mastectomy. Int J Radiat Oncol Biol Phys. 2009 Dec 1; 75(5):1297-303.
    View in: PubMed
  51. Goldberg SI, Niemierko A, Turchin A. Analysis of data errors in clinical research databases. AMIA Annu Symp Proc. 2008; 242-6.
    View in: PubMed
  52. Orton CG, Bortfeld TR, Niemierko A, Unkelbach J. The role of medical physicists and the AAPM in the development of treatment planning and optimization. Med Phys. 2008 Nov; 35(11):4911-23.
    View in: PubMed
  53. Yang JY, Niemierko A, Yang MQ, Deng Y. Analyzing adjuvant radiotherapy suggests a non monotonic radio-sensitivity over tumor volumes. BMC Genomics. 2008; 9 Suppl 2:S9.
    View in: PubMed
  54. Kozin SV, Niemierko A, Huang P, Silva J, Doppke KP, Suit HD. Inter- and intramouse heterogeneity of radiation response for a growing paired organ. Radiat Res. 2008 Aug; 170(2):264-7.
    View in: PubMed
  55. Katz A, Smith BL, Golshan M, Niemierko A, Kobayashi W, Raad RA, Kelada A, Rizk L, Wong JS, Bellon JR, Gadd M, Specht M, Taghian AG. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol. 2008 May 1; 26(13):2093-8.
    View in: PubMed
  56. Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, Bellon JR, Wong JS, Smith BL, Harris JR. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol. 2008 May 10; 26(14):2373-8.
    View in: PubMed
  57. Sher DJ, Wolfgang JA, Niemierko A, Choi NC. Quantification of mediastinal and hilar lymph node movement using four-dimensional computed tomography scan: implications for radiation treatment planning. Int J Radiat Oncol Biol Phys. 2007 Dec 1; 69(5):1402-8.
    View in: PubMed
  58. Azmandian F, Kaeli D, Dy JG, Hutchinson E, Ancukiewicz M, Niemierko A, Jiang SB. Towards the development of an error checker for radiotherapy treatment plans: a preliminary study. Phys Med Biol. 2007 Nov 7; 52(21):6511-24.
    View in: PubMed
  59. Gay HA, Niemierko A. A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy. Phys Med. 2007 Dec; 23(3-4):115-25.
    View in: PubMed
  60. Suit H, Goldberg S, Niemierko A, Ancukiewicz M, Hall E, Goitein M, Wong W, Paganetti H. Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat Res. 2007 Jan; 167(1):12-42.
    View in: PubMed
  61. Lawenda BD, Smith DE, Xu L, Niemierko A, Silverstein JR, Boucher Y, Kashiwagi S, Held KD, Jain RK, Loeffler JS, Eisenberg DM, Blumberg JB. Do the dietary supplements epigallocatechin gallate or vitamin e cause a radiomodifying response on tumors in vivo? A pilot study with murine breast carcinoma. J Soc Integr Oncol. 2007; 5(1):11-7.
    View in: PubMed
  62. Floyd SR, Buchholz TA, Haffty BG, Goldberg S, Niemierko A, Raad RA, Oswald MJ, Sullivan T, Strom EA, Powell SN, Katz A, Taghian AG. Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5 cm and larger. Int J Radiat Oncol Biol Phys. 2006 Oct 1; 66(2):358-64.
    View in: PubMed
  63. Katz A, Niemierko A, Gage I, Evans S, Shaffer M, Fleury T, Smith FP, Petrucci PE, Flax R, Drogula C, Magnant C. Can axillary dissection be avoided in patients with sentinel lymph node metastasis? J Surg Oncol. 2006 Jun 1; 93(7):550-8.
    View in: PubMed
  64. Katz A, Niemierko A, Gage I, Evans S, Shaffer M, Smith FP, Taghian A, Magnant C. Factors associated with involvement of four or more axillary nodes for sentinel lymph node-positive patients. Int J Radiat Oncol Biol Phys. 2006 May 1; 65(1):40-4.
    View in: PubMed
  65. Pieters RS, Niemierko A, Fullerton BC, Munzenrider JE. Cauda equina tolerance to high-dose fractionated irradiation. Int J Radiat Oncol Biol Phys. 2006 Jan 1; 64(1):251-7.
    View in: PubMed
  66. Taghian AG, Assaad SI, Niemierko A, Floyd SR, Powell SN. Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer? Int J Radiat Oncol Biol Phys. 2005 Jun 1; 62(2):386-91.
    View in: PubMed
  67. Lawenda BD, Gagne HM, Gierga DP, Niemierko A, Wong WM, Tarbell NJ, Chen GT, Hochberg FH, Loeffler JS. Permanent alopecia after cranial irradiation: dose-response relationship. Int J Radiat Oncol Biol Phys. 2004 Nov 1; 60(3):879-87.
    View in: PubMed
  68. Marucci L, Niemierko A, Liebsch NJ, Aboubaker F, Liu MC, Munzenrider JE. Spinal cord tolerance to high-dose fractionated 3D conformal proton-photon irradiation as evaluated by equivalent uniform dose and dose volume histogram analysis. Int J Radiat Oncol Biol Phys. 2004 Jun 1; 59(2):551-5.
    View in: PubMed
  69. Niemierko A. Quality assurance and validation of individual IMRT treatment plans before delivery. Med Phys. 2004 Feb; 31(2):421-2.
    View in: PubMed
  70. Thieke C, Bortfeld T, Niemierko A, Nill S. From physical dose constraints to equivalent uniform dose constraints in inverse radiotherapy planning. Med Phys. 2003 Sep; 30(9):2332-9.
    View in: PubMed
  71. Loeffler JS, Niemierko A, Chapman PH. Second tumors after radiosurgery: tip of the iceberg or a bump in the road? Neurosurgery. 2003 Jun; 52(6):1436-40; discussion 1440-2.
    View in: PubMed
  72. Suit H, Goldberg S, Niemierko A, Trofimov A, Adams J, Paganetti H, Chen GT, Bortfeld T, Rosenthal S, Loeffler J, Delaney T. Proton beams to replace photon beams in radical dose treatments. Acta Oncol. 2003; 42(8):800-8.
    View in: PubMed
  73. Choi NC, Fischman AJ, Niemierko A, Ryu JS, Lynch T, Wain J, Wright C, Fidias P, Mathisen D. Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2002 Nov 15; 54(4):1024-35.
    View in: PubMed
  74. Chawla AK, Kachnic LA, Taghian AG, Niemierko A, Zapton DT, Powell SN. Radiotherapy and breast reconstruction: complications and cosmesis with TRAM versus tissue expander/implant. Int J Radiat Oncol Biol Phys. 2002 Oct 1; 54(2):520-6.
    View in: PubMed
  75. Deasy JO, Niemierko A, Herbert D, Yan D, Jackson A, Ten Haken RK, Langer M, Sapareto S. Methodological issues in radiation dose-volume outcome analyses: summary of a joint AAPM/NIH workshop. Med Phys. 2002 Sep; 29(9):2109-27.
    View in: PubMed
  76. Paganetti H, Niemierko A, Ancukiewicz M, Gerweck LE, Goitein M, Loeffler JS, Suit HD. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys. 2002 Jun 1; 53(2):407-21.
    View in: PubMed
  77. Wu Q, Mohan R, Niemierko A, Schmidt-Ullrich R. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys. 2002 Jan 1; 52(1):224-35.
    View in: PubMed
  78. Taghian AG, Assaad SI, Niemierko A, Kuter I, Younger J, Schoenthaler R, Roche M, Powell SN. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst. 2001 Dec 5; 93(23):1806-11.
    View in: PubMed
  79. Mystkowska ET, Niemierko A, Komar A, Sawicki W. Embryotoxicity of magainin-2-amide and its enhancement by cyclodextrin, albumin, hydrogen peroxide and acidification. Hum Reprod. 2001 Jul; 16(7):1457-63.
    View in: PubMed
  80. Stavreva N, Niemierko A, Stavrev P, Goitein M. Modelling the dose-volume response of the spinal cord, based on the idea of damage to contiguous functional subunits. Int J Radiat Biol. 2001 Jun; 77(6):695-702.
    View in: PubMed
  81. Stavrev P, Stavreva N, Niemierko A, Goitein M. Generalization of a model of tissue response to radiation based on the idea of functional subunits and binomial statistics. Phys Med Biol. 2001 May; 46(5):1501-18.
    View in: PubMed
  82. Levin-Plotnik D, Hamilton RJ, Niemierko A, Akselrod S. A model for optimizing normal tissue complication probability in the spinal cord using a generalized incomplete repair scheme. Radiat Res. 2001 Apr; 155(4):593-602.
    View in: PubMed
  83. Levin-Plotnik D, Niemierko A, Akselrod S. Effect of incomplete repair on normal tissue complication probability in the spinal cord. Int J Radiat Oncol Biol Phys. 2000 Feb 1; 46(3):631-8.
    View in: PubMed
  84. Terahara A, Niemierko A, Goitein M, Finkelstein D, Hug E, Liebsch N, O'Farrell D, Lyons S, Munzenrider J. Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma. Int J Radiat Oncol Biol Phys. 1999 Sep 1; 45(2):351-8.
    View in: PubMed
  85. Niemierko A. Prediction of overall pulmonary function loss in relation to the 3D dose distribution for patients with breast cancer and malignant lymphoma. Radiother Oncol. 1999 Aug; 52(2):195-7.
    View in: PubMed
  86. Niemierko A. Radiobiological models of tissue response to radiation in treatment planning systems. Tumori. 1998 Mar-Apr; 84(2):140-3.
    View in: PubMed
  87. MacKay RI, Niemierko A, Goitein M, Hendry JH. Potential clinical impact of normal-tissue intrinsic radiosensitivity testing. Radiother Oncol. 1998 Feb; 46(2):215-6.
    View in: PubMed
  88. Niemierko A. Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys. 1997 Jan; 24(1):103-10.
    View in: PubMed
  89. Hartford AC, Niemierko A, Adams JA, Urie MM, Shipley WU. Conformal irradiation of the prostate: estimating long-term rectal bleeding risk using dose-volume histograms. Int J Radiat Oncol Biol Phys. 1996 Oct 1; 36(3):721-30.
    View in: PubMed
  90. Goitein M, Niemierko A. Intensity modulated therapy and inhomogeneous dose to the tumor: a note of caution. Int J Radiat Oncol Biol Phys. 1996 Sep 1; 36(2):519-22.
    View in: PubMed
  91. Serago CF, Thornton AF, Urie MM, Chapman P, Verhey L, Rosenthal SJ, Gall KP, Niemierko A. Comparison of proton and x-ray conformal dose distributions for radiosurgery applications. Med Phys. 1995 Dec; 22(12):2111-6.
    View in: PubMed
  92. Okunieff P, Morgan D, Niemierko A, Suit HD. Radiation dose-response of human tumors. Int J Radiat Oncol Biol Phys. 1995 Jul 15; 32(4):1227-37.
    View in: PubMed
  93. Niemierko A, Goitein M. Dose-volume effects in the spinal cord. Radiother Oncol. 1994 Jun; 31(3):265-7.
    View in: PubMed
  94. Niemierko A, Goitein M. Dose-volume distributions: a new approach to dose-volume histograms in three-dimensional treatment planning. Med Phys. 1994 Jan; 21(1):3-11.
    View in: PubMed
  95. Niemierko A, Goitein M. Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor. Radiother Oncol. 1993 Nov; 29(2):140-7.
    View in: PubMed
  96. Niemierko A, Goitein M. Comments on "Sampling techniques for the evaluation of treatment plans" [Med. Phys. 20, 151-161 (1993)]. Med Phys. 1993 Sep-Oct; 20(5):1377-80; author reply 1381-5.
    View in: PubMed
  97. Niemierko A, Goitein M. Modeling of normal tissue response to radiation: the critical volume model. Int J Radiat Oncol Biol Phys. 1993 Jan; 25(1):135-45.
    View in: PubMed
  98. Niemierko A, Komar A. Effect of phorbol ester PMA and puromycin on the maturation of mouse oocytes. Cytobios. 1992; 70(280):7-17.
    View in: PubMed
  99. Niemierko A. Random search algorithm (RONSC) for optimization of radiation therapy with both physical and biological end points and constraints. Int J Radiat Oncol Biol Phys. 1992; 23(1):89-98.
    View in: PubMed
  100. Niemierko A, Urie M, Goitein M. Optimization of 3D radiation therapy with both physical and biological end points and constraints. Int J Radiat Oncol Biol Phys. 1992; 23(1):99-108.
    View in: PubMed
  101. Niemierko A, Goitein M. Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture. Radiother Oncol. 1991 Mar; 20(3):166-76.
    View in: PubMed
  102. Niemierko A, Goitein M. Random sampling for evaluating treatment plans. Med Phys. 1990 Sep-Oct; 17(5):753-62.
    View in: PubMed
  103. Niemierko A, Goitein M. The use of variable grid spacing to accelerate dose calculations. Med Phys. 1989 May-Jun; 16(3):357-66.
    View in: PubMed
  104. Niemierko A, Goitein M. The influence of the size of the grid used for dose calculation on the accuracy of dose estimation. Med Phys. 1989 Mar-Apr; 16(2):239-47.
    View in: PubMed
  105. Niemierko A, Michalski W. [Analysis and optimization of the integral dose in radiotherapy of neoplasms using the "box" technique]. Nowotwory. 1989 Jan-Mar; 39(1):60-4.
    View in: PubMed
  106. Niemierko A, Komar A. Action of phorbol myristate acetate (PMA) at fertilization of mouse oocytes in vitro. J Embryol Exp Morphol. 1985 Dec; 90:171-7.
    View in: PubMed
  107. Niemierko A. Properties of the zona pellucida of cytochalasin B-induced triploid mouse eggs. J Reprod Fertil. 1985 Mar; 73(2):313-6.
    View in: PubMed
  108. Niemierko A, Bulski W, Kawczynska M, Meder J, Danczak-Ginalska Z. [Dosimetry and treatment planning in Hodgkin's disease by mantle field radiotherapy]. Nowotwory. 1982 Jan-Jun; 32(1-2):49-56.
    View in: PubMed
  109. Niemierko A. Postimplantation development of CB-induced triploid mouse embryos. J Embryol Exp Morphol. 1981 Dec; 66:81-9.
    View in: PubMed
  110. Niemierko A. [Induction of triploidy and the development of triploid mouse embryos]. Probl Med Wieku Rozwoj. 1981; 10:223-32.
    View in: PubMed
  111. Mystkowska ET, Ozdzenski W, Niemierko A. Factors regulating the degree and extent of experimental chimaerism in the mouse. J Embryol Exp Morphol. 1979 Jun; 51:217-25.
    View in: PubMed
  112. Niemierko A, Komar A. Cytochalasin B-induced triploidy in mouse oocytes fertilized in vitro. J Reprod Fertil. 1976 Nov; 48(2):279-84.
    View in: PubMed
  113. Niemierko A. Induction of triploidy in the mouse by cytochalasin B. J Embryol Exp Morphol. 1975 Oct; 34(2):279-89.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Niemierko's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department